Flora Growth Corp. has signed a strategic supply agreement with Blossom Genetics to bring Colombian medical cannabis to the German market. This partnership will introduce two exotic strains, Chemmy Jones and Northern Lights, to Germany.
Flora's wholly-owned subsidiaries have been active in Germany since 2017, obtained the first medical cannabis license in Germany, and are responsible for selling the first gram of medical cannabis in the country. Flora also has an EU-GMP facility in the country.
Clifford Starke, Chairman and Chief Executive Officer, commented, "This supply agreement with Blossom Genetics is a pivotal step in our efforts to expand Flora's global presence and provide top-tier cannabis products to Germany. The demand for medical cannabis has surged since legalization, and we are confident that the strains we will bring to the market, will resonate with patients and healthcare providers alike."
For more information:
Flora Growth
www.floragrowth.com
Blossom Genetics
blossompharma.com